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Throughout the twenty-first century, evidence has been continually increasing to show 
the importance of epigenetic regulation in health. While the term “epigenetics” can be 
applied to many different processes, the focus of this dissertation will be on microRNAs 
and chromatin structure. Ultimately, both of these forms of epigenetic regulation can be 
used to fine tune gene expression based on environmental cues. The first three chapters of 
the dissertation focus on microRNA bioavailability, stability, and function from two 
commonly consumed food products: cow’s milk and chicken eggs. This important work 
has been the first of its kind to demonstrate the bioavailability and function of dietary, 
animal-based microRNAs. In order to test our hypothesis that dietary microRNA are 
indeed bioavailable, many experimental protocols have been used. Human feeding 
studies are the prominent tool used, but important discoveries have been made in cell 
culture and in a mouse feeding study that add to the significance of this work. The final 
chapter will focus on a well-known histone modifier: sulforaphane. There have been 
many positive roles attributed to this compound, but the work presented here describes 
some potentially negative consequences of high sulforaphane intake. Overall, the 
conclusion of this work is dietary microRNA are bioavailable and can regulate 
endogenous gene expression. For the scientific field to determine the contribution of 
dietary microRNAs to overall health, much more work will need to be performed but the 
evidence provided in this dissertation indicates it is likely dietary microRNAs play a key 
role in overall epigenetic regulation. Ongoing studies in our laboratory to further this 
work and answer some of the current questions are also briefly described. 
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INTRODUCTION 
While one of just many layers of determining overall gene activity, epigenetic control is 
an important factor for determining the phenotype at the cellular and organism level. 
Literally meaning “over, outside, or around” the genome, epigenetics can refer to many 
biological events that influence gene expression. One type of epigenetic regulation that is 
constantly receiving more interest is non-coding RNA. Non-coding RNA can be broken 
down into many subsets including, but not limited to, long non-coding RNA (lncRNA), 
piwi interacting RNA (piRNA), and microRNAs (miRNAs). MiRNA, consisting of non-
coding RNAs 18-23 nucleotides in length, have received special attention for the role 
they play in regulating gene expression (1). In spite of not coding for a protein, miRNA 
have been identified as having key roles in many cellular functions, including 
developmental timing, cell proliferation and death, hematopoiesis, and nervous system 
patterning (2).  
Canonical miRNA function is accomplished by depressing protein expression of a target 
gene through binding to that target gene’s mRNA in the  3’ untranslated region (UTR) 
(3). The seed sequence, made of nucleotides 2-7 in a mature microRNA, is of particular 
importance for binding to target transcripts (4). The mechanism by which this occurs can 
be through impairing protein translation or by marking the target gene mRNA for 
degradation (Fig. 1) (5, 6). While the seed sequence typically needs to be a complete 
match to the target mRNA for any gene regulation to occur, the similarity, or lack 
thereof, of the remaining miRNA sequence to its target will determine whether 
translational inhibition or mRNA degradation are the predominant form of activity.  
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Figure 1. Biogenesis and function of microRNA. Mature microRNA result from 
processing in the nucleus and cytoplasm and once loaded into protein complexes can 
inhibit mRNA stability or protein translation. (Adapted from Filipowicz, 2008) 
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Traditionally, miRNA synthesized in one cell were viewed as specifically regulating 
genes within the same cell. Over time, this view has expanded to include transfer of 
miRNA from one cell type to another in the same and even distal tissues in the body, 
typically through the use of extracellular vesicles (7, 8). 
Furthermore, there is precedent for the transfer cross-kingdom transfer of miRNA 
through the diet. This research suggested that miRNA-168a from rice is detectable in 
human and animal sera, and osa-miR-168a decreases the expression of low-density 
lipoprotein receptor adapter protein 1 mRNA, thereby inhibiting LDL receptor expression 
in mouse liver (9). While the results from this initial study were very interesting, the 
attempts by other researchers to replicate the data have been, in most cases, contradictory. 
In short, the bioavailability of plant-borne microRNAs in humans is controversial (10-
13). 
While there are many uncertainties regarding plant-borne miRNA bioavailability, there is 
reason to suspect animal-borne miRNA are more likely to survive digestive conditions 
and cross the intestinal barrier. Along with other nucleic acids and compounds, miRNA 
are known to be protected from the surrounding environment by extracellular vesicles 
(Fig. 2) (14, 15) One type of these vesicles, exosomes, have surface proteins that might 
be important for efficient cellular uptake (16, 17). Plants may have similar structures, but 
the identity and amino acid sequence of the surface proteins could be different, which in 
turn would likely negatively affect the uptake of plant exosomes by human intestinal 
cells.  
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Figure 2. Exosome secretion, stability, and uptake. Initially formed from 
multivesicular bodies, exosomes are secreted into the extracellular space where the 
exosomal phospholipid bilayer protects the contents from external conditions until the 
exosome is taken up by a recipient cell via endocytosis and the contents are unpackaged. 
(Adapted from Stoorvogel, 2012) 
Histone modifications are another subset of epigenetic changes that can lead to greater or 
lesser gene expression based on the placement and type of modification made to the 
histone. One type of well-known modification is histone acetylation, which takes place at 
lysine residues and typically is associated with greater transcriptional activation (18). 
Equally important in overall gene regulation, the cell has histone deacetylase (HDAC) 
proteins to remove the acetyl groups from histones when the gene activation they induce 
is no longer needed.  
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Epigenetic regulation by dietary compounds may explain some of the presumed health 
benefits of foods not explained by traditional nutrition. One widely studied food 
compound, found exclusively in cruciferous vegetables, is sulforaphane (SFN). SFN is 
purported to have many positive characteristics, including the ability to activate tumor 
suppressor genes and reduce inflammation (19). There are different hypotheses to explain 
the cellular responses seen with the administration of SFN, but one that has been 
experimentally validated is the ability of SFN to act as a histone deacetylase (HDAC) 
inhibitor (19, 20). Once taken up by a cell, sulforaphane is metabolized into a number of 
different compounds. While they all confer differing levels of biological activity, SFN-
Cysteine seems to have the best HDAC inhibitory activity (20). Experimental and 
computer modeling results indicate SFN-Cysteine probably functions as a competitive 
inhibitor (Fig. 3). 
By lowering the amount of HDAC activity in cells, there can be greater acetylation in the 
promoter of genes responsive to HDACs. With regard to observed studies on SFN, 
suppression of HDAC activity can lead to greater activation of tumor suppressor genes, 
such as p21. Through the additional protection conferred by having greater p21 
expression, SFN acts as a chemoprotective compound. Importantly, the activity of SFN in 
this manner affects hundreds of genes, as at least 2% of genes are responsive to changing 
activity of HDACs (21). Additionally, many of those genes are microRNA genes which 
may have second degree effects on many other downstream targets. 
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Figure 3. Modeling of a sulforaphane/HDAC interaction. One of the metabolites of 
sulforaphane, sulforaphane-cysteine fits into the HDAC active site, providing a 
mechanism by which sulforaphane inhibits HDAC activity. (Adapted from Dashwood, 
2005) 
 
One set of genomic loci known to be responsive to hyperacetylation of histones are long-
terminal repeats (LTRs) (22). While these loci are typically heavily repressed, they can 
become active with increased acetylation and when they are de-repressed, it leads to 
higher risk of cancer and chromosomal abnormalities (23-29). LTRs can exist in a 
solitary form, meaning it is simply the promoter elements of the retrotransposon at a 
given genomic loci or they can exist as an in-tact LTR, meaning there are endogenous 
retrovirus sequences present along with the promoter sequences. While most LTRs exist 
in the solitary form, at least 60 in-tact, transcriptionally active LTRs have been identified 
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(30). By modification of global acetylation levels, retrotransposons may become active 
potentially resulting in translocation from one genomic loci to another (Fig. 4). 
Depending on the insertion site of the retrotransposon, the result can be benign or severe, 
potentially resulting in tumor suppressor inactivation, oncogene activation, or disruption 
of other essential genes (31-33). 
 
Figure 4. Retrotransposon translocates between different genomic loci. The de-
repression of LTRs activates retro-transcription from its promoter, allowing its associated 
retrotransposon to be transferred from the donor loci to recipient loci in the genome. 
(Adapted from Lewin, 2004) 
 
Conclusion 
Epigenetic regulation of genes may occur through many different mechanisms. 
Transcriptional activity can be increased or decreased by modifying histone positioning 
based on environmental cues. Even more interestingly, microRNA present in the foods 
we eat may directly be regulating expression of endogenous genes. The following 
chapters will explore these ideas further and describe in detail the (i) the bioavailability of 
milk-derived microRNA as demonstrated in cell culture studies, human feeding studies, 
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and mouse feeding experiments, (ii) the bioavailability of chicken egg-derived 
microRNA and the biological activity of those exogenous microRNA, (iii) the stability of 
milk microRNA throughout processing and conversion of milk into other food products,  
and (iv) activation of LTRs following consumption of broccoli sprouts by human 
subjects. 
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Abstract 1 
Background MicroRNAs regulate genes in animals and plants, and can be synthesized 2 
endogenously. In milk, microRNAs are encapsulated in exosomes, thereby conferring 3 
protection against degradation and facilitating uptake by endocytosis. The majority of 4 
bovine microRNAs have nucleotide sequences complimentary to human gene transcripts, 5 
suggesting that microRNAs in milk might regulate human genes.  6 
Objective We tested the hypotheses that humans absorb biologically meaningful 7 
microRNAs from nutritionally relevant doses of milk, milk-borne microRNAs regulate 8 
human gene expression, and mammals cannot compensate for dietary microRNAs 9 
depletion by endogenous microRNA synthesis.  10 
Methods Healthy adults (3 male, 2 female, ages 26-49 years) consumed 0.25, 0.5, and 1.0 11 
liter milk in a randomized cross-over design. Gene expression studies and milk 12 
microRNA depletion studies were conducted in human cell cultures and mice, 13 
respectively. For comparison, feeding studies with plant microRNAs from broccoli were 14 
conducted in humans. 15 
Results Postprandial concentration time curves suggest that meaningful amounts of 16 
microRNA-29b (miR-29b) and microRNA-200c (miR-200c) were absorbed; plasma 17 
concentrations of miR-1 did not change (negative control). The expression of RUNX2, a 18 
known target of miR-29b, increased by 31% in blood mononuclear cells following milk 19 
consumption compared with baseline. When milk exosomes were added to cell culture 20 
media, mimicking postprandial concentrations of miR-29b and miR200c, reporter gene 21 
activities significantly decreased by 44% and 17%, respectively, compared with vehicle 22 
controls in HEK-293 human kidney cells. When C57BL/6J mice were fed a milk 23 
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microRNA-depleted diet for four weeks, plasma miR-29b levels were significantly 24 
decreased by 61% compared with microRNA-sufficient controls, i.e., endogenous 25 
synthesis did not compensate for dietary depletion. Broccoli sprout feeding studies were 26 
conducted as a control and elicited no detectable increase in brassica-specific microRNA.  27 
Conclusion We conclude that microRNAs in milk are bioactive food compounds that 28 
regulate human genes. 29 
 30 
Key words: bioavailability; bone health; dietary miRNA; milk; miR-29b  31 
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Introduction 32 
MicroRNAs are small non-coding RNA (about 22 nucleotides in mature microRNA) that 33 
may silence genes via destabilizing complementary mRNA sequences or preventing 34 
translation of mRNA (1, 2). The nucleotide sequence in the seed region in microRNA 35 
(nucleotides 2-7) is of particular importance for binding to target (3); imperfect pairing of 36 
sequences in the seed region in microRNA to mRNA impairs gene downregulation at the 37 
protein or RNA level (4). MicroRNAs are encoded by their own genes, introns, or exons 38 
of long nonprotein-coding transcripts (5). Traditionally, microRNAs are considered 39 
endogenous regulators of genes, i.e., microRNAs synthesized by human cells regulate the 40 
expression of genes in that host. We challenged this paradigm and tested the hypothesis 41 
that humans absorb microRNAs from milk in meaningful quantities and milk-borne 42 
microRNAs elicit biologically meaningful changes in human gene expression. 43 
There is precedent for the bioavailability of dietary microRNAs in humans. A recent 44 
report suggests that microRNA-168a from rice (Oryza sativa, osa-miR-168a) is 45 
detectable in human and animal sera, and osa-miR-168a decreases the expression of low-46 
density lipoprotein receptor adapter protein 1 mRNA, thereby inhibiting LDL receptor 47 
expression in mouse liver (6). Note that the serum concentration of osa-miR-168a is only 48 
about 3 fmol/L in humans and that the bioavailability of plant-borne microRNAs in 49 
humans is controversial (6-10). 50 
This study focused on milk as source of dietary microRNAs, based on the rationale 51 
that a large fraction of microRNAs in milk is contained in exosomes, conferring 52 
protection against degradation (11, 12), Americans consume 195 pounds of milk annually 53 
(13), and cow’s milk contains large quantities of 245 microRNA (14, 15). This study of 54 
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milk-borne microRNAs was modeled primarily on miR-29b based on the rationale that 55 
the nucleotide sequence of bovine miR-29b is identical to that of human miR-29b (16), 56 
and miR-29b increases bone mineralization in humans through promoting a gain in 57 
osteoblast differentiation (17) and a loss in osteoclast differentiation and function (18). In 58 
select experiments, miR-200c was included because its concentration is eight times that 59 
of miR-29b in cow’s milk (15). The nucleotide sequence of bovine miR-200c is identical 60 
to that of human miR-200c (16), and miR-200c decreases cancer risk by targeting the 61 
transcription factor zinc finger E-box binding homeobox 1 (ZEB16);  miR-62 
200c―dependent loss of ZEB1 induces E-cadherin expression, thereby limiting 63 
epithelial-to-mesenchymal transition ― a key event in metastasis (19, 20). 64 
This study was guided by the following aims. First, we determined whether humans 65 
absorb quantitatively meaningful amounts of microRNA from nutritionally relevant doses 66 
of milk, and characterized the bioavailability of milk microRNAs using pharmacokinetics 67 
protocols. Second, we assessed the effects of physiologically relevant microRNA 68 
concentrations on the expression of endogenous genes in human peripheral blood 69 
mononuclear cells (PBMC)6 and reporter genes in human cell cultures. Third, we 70 
determined whether mammals compensate for dietary microRNA deficiency by an 71 
increased synthesis of endogenous microRNAs in a mouse microRNA depletion study. 72 
Fourth, we conducted a broccoli feeding study to determine whether plant-borne 73 
microRNAs are bioavailable in humans. 74 
 75 
Methods and Materials 76 
 
 
21 
  
Human feeding study. Five apparently healthy adults (3 male, 2 female) participated in a 77 
milk feeding study using three doses of milk in a randomized cross-over design with a 78 
washout period of at least a one week between doses. Exclusion criteria included 79 
pregnancy, smoking, milk allergies, and self-reported health problems. Preliminary 80 
studies suggested that plasma miRNA concentrations remain higher than baseline 81 
concentrations until 9 hours after milk consumption; subjects were instructed not to 82 
consume milk and dairy products for twelve hours before the milk meal and during the 83 
period in which blood samples were collected. Doses of milk were normalized by total 84 
body water of subjects, which is the suspected volume of distribution for microRNA. 85 
Estimation of total body water was calculated as previously described (21). 86 
Normalization of doses by body water resulted in doses of 0.218 ± 0.018, 0.436 ± 0.037, 87 
and, 0.872 ± 0.073 L representing the equivalent of 0.25 L, 0.5 L, and 1.0 L in a 26 year-88 
old reference male (75 kg weight, 1.83 m height). Twenty milliliters of blood were 89 
collected before milk consumption (baseline, time 0 h) and at timed intervals (1, 2, 3, 6, 90 
9, 24 h) after the milk meal. PBMC and plasma were collected using gradient 91 
centrifugation as described previously (22) and frozen at -80°C until analysis. This 92 
protocol was approved by the University of Nebraska-Lincoln Institutional Review Board 93 
and all participants provided signed informed consent forms prior to participation. 94 
  95 
Quantitative real-time PCR (qRT-PCR). The sequences of mature bovine miR-29b (bta-96 
miR-29), miR-200c (bta-miR-200c), and miR-1 (bta-miR-1; control) are identical to their 97 
human and murine orthologs and, therefore, qRT-PCR amplification targeted the mature 98 
human miR-29b (hsa-miR-29b-3p), miR-200c (hsa-miR-200c-3p), and miR-1 (hsa-miR-99 
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1-3p) that originate in the 3’ p arm of pre-miRNA (23). RNA was isolated from human 100 
and murine (see below) plasma using the NucleoSpin miRNA Plasma kit (Machery-101 
Nagel, Bethlehem, PA). Reverse transcription was performed using the miScript II RT 102 
Kit. qRT-PCR was performed using miScript SYBR Green (Qiagen, Valencia, CA) and 103 
the universal reverse primer included in the kit primers specific for individual microRNA 104 
(Supplemental Table 1). MicroRNA-1 is not detectable in milk (data not shown) and 105 
served as negative control. Five attomoles of synthetic miRNA, miSPIKE (IDT DNA, 106 
Coralville, IA), were added to each sample after denaturation of plasma with lysis buffer 107 
and served as external standard and for calibration of qRT-PCR.  108 
 109 
Pharmacokinetics analysis. Areas under the curves for plasma miRNA were calculated 110 
using the linear trapezoidal rule to assess the apparent bioavailability of microRNA (24). 111 
Plasma concentrations of miR-29b and miR-200c returned to baseline levels nine hours 112 
after consumption of the two lowest doses of milk. For the calculation of AUC, baseline 113 
values were subtracted from postprandial concentrations and the plasma concentrations 114 
from the first nine hours after milk meals were used. The maximal plasma concentration 115 
(Cmax) and the time of peak concentration (tmax) were obtained by visual inspection of the 116 
plasma time curves measured for miR-29b and miR-200c. Cmax of an orally administered 117 
compound is a marker of bioavailability and rate of absorption, whereas tmax is a marker 118 
of the approximate absorption site (25). 119 
 120 
Gene expression. Effects of milk-borne microRNAs on the expression of human genes 121 
were assessed in cell cultures and PBMC from the human milk feeding studies. For 122 
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studies in cell cultures, HEK-293 human embryonic kidney cells (American Type Culture 123 
Collection, Manassas, VA) were cultured in Minimum Essential Medium containing 10% 124 
exosome-depleted fetal bovine serum, 0.1% sodium pyruvate, 100,000 U/L penicillin, 125 
and 100 mg/L streptomycin for 10 days. Bovine serum was depleted of exosomes by 126 
ultracentrifugation at 130,000 x g for 4 hours, leading to the removal of 97% and 81% of 127 
miR-29b and miR-200c, respectively. Cells were transfected with microRNA reporter 128 
genes as described previously (26). Forty-eight hours after transfection, exosome-129 
depleted media was replaced with exosome-sufficient media at final concentrations of 130 
600 fmol/L miR-29b or 1000 fmol/L miR-200c. Exosome-sufficient media were prepared 131 
using exosomes collected from cow’s milk as previously described (27). The 132 
concentrations of miR-29b and miR-200c in exosomes were quantified using qRT-PCR, 133 
and exosomes were added back to culture media to produce the desired concentrations of 134 
microRNA. Reporter genes for miR-29b and miR-200c were created by inserting the 3’-135 
untranslated regions (3’-UTR) from genes COL1A1 (three miR-29b binding sites) and 136 
ZEB1 (two miR-200c binding sites), respectively, downstream of the luciferase reading 137 
frame, driven by a cytomegalovirus promoter, thereby creating plasmids LUC-mir29b 138 
and LUC-mir200c (Supplemental Fig. 1). LUC-mir200c was obtained from Dr. Thomas 139 
Brabletz (University of Freiburg, Germany) and is denoted ZEB1 3’UTR-Luc in the 140 
original publication (20). LUC-mir29b was created by digesting LUC-mir200c with MluI 141 
and HindIII to remove the ZEB1 sequence. The 3’-untranslated regions of COL1A1 was 142 
amplified by PCR (Supplemental Table 1) using IMR-90 fibroblast DNA as template 143 
and ligated into the reporter plasmid using MluI and HindIII. Cells were co-transfected 144 
with plasmid RSV-β-galactosidase and luciferase plasmids to assess transfection 145 
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efficiency (28). Reporter gene activities were normalized by transfection efficiency. Our 146 
rationale for choosing HEK-293 cells was that these cells can be transfected with near 147 
100% efficiency and express COL1A1 in meaningful quantities (29, 30). 148 
For studies in human PBMC, a preliminary time-response screen was conducted to 149 
determine the time point when the effects of milk on the expression of Runt-related 150 
transcription factor 2 (RUNX2) and , zinc finger E-box binding homeobox 1 (ZEB1) 151 
mRNA were maximal. RUNX2 is a downstream target of miR-29b-dependent signaling 152 
pathways; note that miR-29b is a positive regulator of the expression of RUNX2 (17). Our 153 
preliminary assessment suggested that changes in mRNA abundance were maximal 6 h 154 
after milk consumption (Supplemental Fig. 2, positive and negative changes for RUNX2 155 
and ZEB1 mRNA, respectively). Therefore, subsequent assays of RUNX2 and ZEB1 156 
mRNA were conducted using samples from time point 6 h after the milk meal, using 157 
qRT-PCR (Online Table 1) and the ΔΔCt method (31); GAPDH was used to normalize 158 
for amplification efficiency (32). Abundance of miRNA was measured as described for 159 
plasma samples except that normalization was performed using U6 rather than miSPIKE. 160 
 161 
 162 
Mouse feeding study. A microRNA depletion study was conducted in mice to determine 163 
whether endogenous microRNA synthesis compensates for dietary deficiency. Ten 164 
female C57BL/6J mice (Jackson Labs, stock 000664), age 3 weeks, were randomly 165 
divided between a milk microRNA-depleted treatment group (denoted ExoMinus) and a 166 
milk microRNA-sufficient control group (ExoPlus). Diets were based on the AIN-93G 167 
formula with the following modifications and were fed for four weeks (33). In the 168 
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ExoMinus diet, exosome-depleted fat-free cow’s milk was substituted for casein and 169 
cornstarch in the AIN-93G diet to provide 10% of total calories (Supplemental Table 2); 170 
the remainder of casein in the AIN-93G diet was replaced with soy protein (Bob’s Red 171 
Mill, Milwaukee, OR) to eliminate any milk-borne microRNAs. Milk was depleted of 172 
exosomes by ultrasonication for 60 min (VWR Aquasonic 250T) and incubation at 37°C 173 
for 60 min prior to lyophilization. Ten percent of calories represent a consumption of 174 
approximately 0.5 liter of fat-free milk by an adult, based on 352 kcal/L milk and an 175 
energy intake of 1760 kcal (34). The ExoPlus control diet was prepared using exosome-176 
containing milk powder, but was otherwise identical to the ExoMinus diet. Components 177 
were blended and dried at 40°C overnight. No miR-29b was detectable in the ExoMinus 178 
diet whereas the ExoPlus diet contained about 83 fmol/g miR-29b, assessed by qRT-179 
PCR. All mouse protocols used in this study were approved by the University of 180 
Nebraska-Lincoln Institutional Animal Care and Use Committee. After four weeks of 181 
feeding microRNA-defined diets, mice were euthanized by carbon dioxide and blood was 182 
collected in EDTA collection tubes. Livers were excised, rinsed with cold saline, and 183 
flash frozen in liquid nitrogen. Ten milligrams of liver were homogenized using lysis 184 
buffer in the NucleoSpin miRNA Kit (Machery-Nagel, Bethlehem, PA) and mRNA was 185 
purified following the manufacturer’s instructions. Reverse transcription was performed 186 
with the High Capacity RNA-to-cDNA Kit (Life Technologies, Grand Island, NY) for 187 
subsequent analysis of Kruppel-like factor 8 (KFL8) expression using qRT-PCR 188 
(Supplemental Table 1).  189 
 190 
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Broccoli-borne microRNAs in humans. The bioavailability of plant-borne microRNAs is 191 
controversial (6-10). We used plasma samples archived from a previous broccoli sprout 192 
feeding study in humans to determine whether broccoli-borne microRNAs are detectable 193 
in prandial plasma samples (35). In this previous study, eight healthy adults were fed 34, 194 
68, and 102 g of broccoli sprouts and timed samples were collected at t = 0, 2, 4, 8, and 195 
24 hours. Here, we analyzed samples collected at t = 0 and 4 h from the highest dose of 196 
broccoli sprouts for miR-824 and miR-167a in four randomly selected subjects. Total 197 
RNA was isolated from 75 mg of broccoli sprouts using Trizol. Samples were analyzed 198 
for miR-824 and miR-167a using qRT-PCR (Supplemental Table 1). As of today, there is 199 
no evidence that humans synthesize miR-824 and miR-167a (36), i.e., the brassica-200 
specific miR-824 and plant-specific miR-167a are good markers of broccoli-borne 201 
microRNAs in human blood. 202 
 203 
Statistics. Homogeneity of variances was tested using Bartlett’s Test. Variances were 204 
heterogeneous for microRNA in mouse plasma, i.e., murine plasma data were log 205 
transformed prior to subsequent statistical analysis. AUC were calculated using 206 
GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA). Pharmacokinetics data were 207 
analyzed using repeated measures analysis of variance (ANOVA) and Fisher’s PLSD for 208 
posthoc comparisons (37). PBMC gene expression data was analyzed using the paired t-209 
test, whereas plasma miRNA concentrations and liver gene expression in mice were 210 
analyzed using the Wilcoxon-Signed Rank Test. StatView 5.0.1 was used for statistical 211 
analyses (SAS Institute; Cary, NC). Differences were considered statistically significant 212 
if p<0.05.  213 
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 214 
Results 215 
 216 
Bioavailability of milk-borne microRNAs in humans. Cow’s milk (1% fat) contained 217 
148±42 pmol/L miR-29b and 680±151 pmol/L miR-200c. Humans absorbed considerable 218 
amounts of miR-29b from cow’s milk (Fig. 1A). In contrast, the plasma concentration of 219 
miR-1 did not change after the consumption of 1 liter milk (negative control). Plasma 220 
miR-29b concentrations returned to baseline concentrations nine hours after the milk 221 
meals for the 0.25-liter and 0.5-liter doses and 24 hours after the 1-liter dose. The AUC 222 
for miR-29b exhibited a linear dose-response relationship regarding the amount of milk 223 
consumed (Table 1). Likewise Cmax increased linearly with the amount of milk 224 
consumed, if Cmax was corrected for baseline concentrations of miR-29b. Tmax was 3.4  to 225 
4.2 hours after the milk meal. MiR-200c is another microRNA present in cow’s milk. 226 
Humans also absorbed considerable amounts of miR-200c from cow’s milk (Fig. 1B). 227 
While the postprandial AUC for miR-200c was significantly higher for the 0.5 L and 1.0 228 
L  doses of milk compared to the 0.25 L dose, the AUC did not exhibit a linear dose-229 
response relationship; the AUC were not significantly different between the 0.5 L dose 230 
and the 1.0 L dose (Table 1). 231 
 232 
Effects of milk microRNAs on the concentrations of microRNAs in human PBMC.  Milk 233 
feeding elicited an increase in the concentrations of microRNA in human PBMC that was 234 
statistically significant only for miR-200c while trending towards significance for miR-235 
29b (P = 0.09) (Fig. 2).  236 
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 237 
Effects of milk microRNAs on human gene expression. MicroRNA-containing milk 238 
exosomes affected the activity of reporter gene plasmids. When HEK-293 cells were 239 
cultured in media supplemented with milk exosomes providing 600 fmol/L miR-29b for 4 240 
h, the activity of the miR-29b―dependent reporter gene LUC-mir29b decreased by 241 
44±13% (P = 0.04) compared with cells cultured in exosome-depleted culture media 242 
(Fig. 3A). Likewise, when HEK-293 cells were cultured in media supplemented with 243 
milk exosomes providing 1000 fmol/L miR-200c for 4 h, the activity of the miR-244 
200c―dependent reporter gene LUC-mir200c decreased by 17±3% (P = 0.02) compared 245 
with cells cultured in exosome-depleted culture media. 246 
Milk feeding caused changes of microRNA target gene expression in human 247 
PBMC. The expression of RUNX2 was 31±13% higher 6 h after the milk meal compared 248 
with time 0 h (Fig. 3B, P = 0.04), consistent with the role of miR-29b as positive 249 
regulator of RUNX2 (17). The difference in the expression of ZEB1 was not significantly 250 
lower 6 h after the milk meal compared with time 0 h (Fig. 3B).  251 
 252 
MicroRNA depletion studies in mice. Endogenous microRNA transcription does not 253 
compensate for dietary deficiency in C57BL/6 mice. When mice were fed miRNA-254 
defined diet for four weeks, the miR-29b plasma concentration decreased by 61% from 255 
152 ± 79 fmol/L in the microRNA-sufficient ExoPlus group to 60 ± 27 fmol/L in the 256 
microRNA-depleted ExoMinus group  (P = 0.04). The expression of KLF8 mRNA was 257 
64±32% lower in microRNA-depleted mice compared with microRNA-sufficient mice (P 258 
= 0.04).  259 
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 260 
Bioavailability of broccoli microRNAs in humans. Broccoli sprouts contained 53±16 261 
pmol/kg of miR-167a and 42±10 pmol/kg miR-824. No change was observed in miR-262 
167a plasma concentration in healthy adults following a broccoli sprout meal (13±4 263 
fmol/L at t=0 h vs. 15±7 fmol/L at t=4 h; P = 0.85; n=4). The concentration of miR-824 264 
was below detection limit (<1 fmol/L) at baseline or 4 h after broccoli sprout feeding in 265 
all of the four subjects randomly chosen from our archived plasma samples (35). 266 
 267 
Discussion 268 
Some non-coding RNA, including microRNAs, play essential roles in gene regulation in 269 
plant and animal kingdoms. To the best of our knowledge, this is the first study to report 270 
that humans absorb quantitatively meaningful amounts of microRNA from nutritionally 271 
relevant amounts of cow’s milk. Our study provides unambiguous evidence that the 272 
amounts of microRNAs absorbed from milk are sufficient to alter human gene 273 
expression, i.e., microRNAs from one mammalian species can affect gene networks in 274 
another species. Our observation that endogenous microRNA synthesis cannot 275 
compensate for dietary deficiency is of particular interest, because it implies that a 276 
regular dietary microRNA intake may be important to prevent aberrant gene regulation. 277 
Our observations are important from the perspective of maintaining human health, 278 
based on the following rationale. First, 245 microRNAs have been identified in cow’s 279 
milk (14). A preliminary analysis by sequence alignment suggests that the majority of the 280 
nucleotide sequences in bovine milk match the sequences of their human orthologs. We 281 
are in the process of developing algorithms for predicting human gene targets for bovine 282 
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microRNAs, and initial assessments suggest that the number of target genes will exceed 283 
11,000. Second, there is unambiguous evidence linking microRNAs with human health. 284 
For example, miR-29b promotes bone health through altering osteoblast and osteoclast 285 
differentiation (17, 18), miR-200c decreases cancer risk by targeting the transcription 286 
factor ZEB1 (19, 20), and miR-15b, miR-21, miR-27b, miR-34a, miR-106b, miR-130a, 287 
miR-155, miR-200c and miR-223 have been implicated in immune function and Crohn’s 288 
disease (15, 38). Third, supplementation and depletion of milk altered microRNA 289 
concentrations and gene expression in human PBMC and mouse liver. For example, the 290 
concentration of miR-200c was greater six hours after a milk meal compared with time 291 
zero in human PBMC. Likewise, the expression of KLF8 mRNA was greater in livers 292 
from milk microRNA-sufficient mice compared with milk microRNA-depleted mice. 293 
Fourth, milk is an important staple in many Western diets. For example, Americans 294 
consume large quantities of milk, despite a steady decline from about 237 pounds in 1987 295 
to 195 pounds in 2012 (13, 39). Note that a large fraction of microRNAs in milk is 296 
contained in exosomes, providing protection against degradation (11, 12). Fifth, mice can 297 
be depleted of microRNAs by feeding a microRNA-depleted diet.  298 
A recent report suggests that miR-168a from rice is detectable in human and 299 
animal sera, and osa-miR-168a decreases the expression of LDL receptor adapter protein 300 
1 in mouse liver (6). The bioavailability of plant-borne microRNAs in humans is 301 
controversial (6-10). Note that this research focuses on milk-borne microRNAs for which 302 
postprandial plasma levels are 200-300 times higher than those reported for osa-miR-303 
168a in humans (6), depending on the species of milk microRNA. We are skeptical of the 304 
bioavailability and biological activity of plant-borne microRNAs and conducted a 305 
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preliminary screen of microRNAs following a meal providing large amounts of broccoli 306 
sprouts. In our broccoli sprouts feeding study, we did not observe a postprandial increase 307 
in the Brassica-specific miR-824 or miR-167a. We speculate that the absence of effect in 308 
broccoli feeding studies might be due to one or some of the following factors. First, 309 
exosomes carry numerous surface proteins that might be important for cellular uptake 310 
(40, 41). The identity and amino acid sequence of surface proteins implicated in the 311 
cellular uptake of exosomes differs between plants and mammals, which might adversely 312 
affect the uptake of plant exosomes by human intestinal cells. Second, it is possible that 313 
the methylation of the 3’-terminal ribose in plant microRNAs by the methyl transferase 314 
HEN1 (42) impairs the intestinal transport of microRNAs. Third, the concentrations of 315 
microRNAs in broccoli sprouts are moderately below the concentrations present in milk. 316 
It is also unclear whether plant-based microRNAs are encapsulated in vesicles that 317 
provide protection against enzymatic and non-enzymatic degradation during food 318 
processing. Fourth, it is possible that the number of human genes with sequences 319 
complimentary to plant microRNAs might be less than those in mammalian microRNAs. 320 
We acknowledge that our broccoli feeding study is associated with some uncertainties, 321 
e.g., random selection of two microRNAs and one postprandial time point. 322 
Notwithstanding these uncertainties, the analysis of samples from the broccoli feeding 323 
study provides a valuable negative control for our studies in milk.  324 
There are some uncertainties associated with our studies of milk microRNAs. 325 
First, this study assessed the apparent bioavailability of microRNAs in milk, without 326 
taking into account metabolism and degradation in intestinal cells and liver. Ongoing 327 
studies of microRNA transport mechanisms suggest that a substantial fraction of some 328 
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microRNA is degraded in intestinal cells. Therefore, our bioavailability data probably 329 
underestimate the true extent of microRNA absorption in humans, as only a fraction of 330 
the absorbed microRNAs will appear in the peripheral circulation. Second our 331 
pharmacokinetics analysis suggests that postprandial plasma microRNA concentrations 332 
peak about three to four hours after milk consumption. The tmax values for microRNAs 333 
are slightly later than tmax observed for the vitamin riboflavin (tmax ~ 2 h) (24), which is 334 
absorbed in the duodenum (43). Considering that milk meals delay gastric emptying (44), 335 
we speculate that milk-borne-microRNAs are absorbed primarily in the upper intestine. 336 
Third, this study focused on miR-29b, miR-200c, and miR-1 (negative control) and did 337 
not formally study other microRNAs in milk. We speculate that milk exosomes enter 338 
human intestinal by a mechanism that is shared by all exosomal microRNAs, and that any 339 
discrimination among microRNAs would only occur after intestinal uptake. 340 
Ongoing and planned activities in our laboratory include the characterization of 341 
intestinal microRNA transport mechanisms, including metabolism and basolateral 342 
secretion, and the characterization of milk microRNA-dependent gene networks in 343 
humans using computational biology approaches. 344 
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TABLE 1 Pharmacokinetics analysis of plasma time curves of microRNAs after milk meals in healthy adults. 
 
 
miR-29b 
 
miR-200c 
 
miR-1 
  Dose  
 
 Dose 
  
Dose 
Variable 0.25 L 0.5 L 1.0 L 
 
0.25 L 0.5 L 1.0L 
 
1.0 L 
Baseline (fmol/L)1 224 ± 43 274 ± 37 232 ± 51 
 
375 ± 81 468 ± 103 458 ± 37 
 
80 ± 21 
Cmax (fmol/L) 372 ± 40
a 484 ± 82ab 624 ± 83b 
 
632 ± 104a 819 ± 123ab 924 ± 121b 
 
91 ± 18 
tmax (h) 4.2 ± 1.5
 3.4 ± 0.7 3.6 ± 0.6 
 
2.6 ± 0.9 3.8 ± 1.0 3.6 ± 0.6 
 
 
AUC (fmol/L*h)2  327 ± 249a 672 ± 231a 1900 ± 275b 
 
646 ± 187a 1800 ± 566b 2260 ± 555b   
Values are means ± SEMs, n=5 
1Plasma concentration at time 0 hours. 
2For hours 0 through 9. 
a,bWithin a variablefor the same miRNA, means without a common letter differ (P < 0.05, n =5). 
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FIGURE 1 Plasma time curves of miR-29b (panel A), miR-1 (negative control, panel A), 
and miR-200c (panel B) following a milk meal in healthy adults.  Values are reported as 
means, n =5. Standard deviations have been omitted for clarity (compare Table 1). 
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FIGURE 2 Effects of milk microRNAs on the abundance of miRNA in human 
peripheral blood mononuclear cells. Values are mean ± SEM, n = 5. * Statistically 
different samples indicated by asterisk, P < 0.05.  
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FIGURE 3 Effects of milk microRNAs on gene expression in humans. (A) Activities of 
microRNA reporter genes in HEK-293 cells. (B) Expression of endogenous RUNX2 and 
ZEB1 genes in PBMC from healthy adults.  Data are mean ± SEM, n = 4 (LUC-miR29b), 
n = 6 (LUC-miR200c), n = 5 (PBMC). *Different from vehicle, P < 0.05. RUNX2, Runt-
related transcription factor 2; ZEB1, zinc finger E-box binding homeobox 1.
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SUPPLEMENTAL TABLE 1 Primers used for the quantification of microRNAs in 
human and murine plasma, mRNA abundance in human 
PBMC and murine livers, and creating the human 
COL1A1 reporter plasmid. 
Amplicon Forward Primer (5’-3’) Reverse Primer (5’-3’) 
miSPIKE CTCAGGATGGCGGAGCGGTCT  
U6 CGCAAGGATGACACGCAAATT  
miR-29b GTAGCACCATTTGAATCAGTGTT  
miR-200c TAATACTGCCGGGTAATGATGGA  
miR-1 TGGAATGTAAAGAAGTATGTAT  
miR-167a TGAAGCTGCCAGCATGATCTA  
miR-824 TAGACCATTTGTGAGAAGGGA  
GAPDH TCCACTGGCGTCTTCACC GGCAGAGATGATGACCCTTT 
ZEB11 TTCAAACCCATAGTGGTTGCT TGGGAGATACCAAACCAACTG 
RUNX2 CGCCCCTCCCTGAACTCT TGCCTGCCTGGGATCTGTA 
KLF8 
(ZNF74) 
CAAGCCATTATGGTGCCTAC ATAGAGCCCGGAGTGAGAAC 
COL1A1 
3’-UTR 
CGTGCGCATTCGGAGGAGAGTC CGAAGCTTGAGGCCTGAGAAGCC 
 
1Abbreviations used: COL1A1, collagen, type I, alpha 1; KLF8, Kruppel-like factor 8; 
RUNX2, runt-related transcription factor 2; ZEB1, zinc finger E-box binding homeobox 1. 
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SUPPLEMENTAL FIGURE 1 Schematic of microRNA reporter plasmids and the β-
gaalctosidase control plasmid. Numerals denote the position of nucleotides in the 3’-UTR 
in collagen, type I, alpha 1(COL1A1, GenBank NM_000088) and zinc finger E-box 
binding homeobox 1( ZEB1, GenBank NM_001128128). 
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SUPPLEMENTAL FIGURE 2 Time courses of runt-related transcription factor 2 
(RUNX2) and zinc finger E-box binding homeobox 1 (ZEB1) mRNA in peripheral blood 
mononuclear cells from an adult male. 
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SUPPLEMENTAL TABLE 2 Composition of microRNA-depleted (ExoMinus) and 
microRNA-sufficient (ExoPlus) diets. 
ExoMinus ExoPlus g/kg 
Cornstarch Cornstarch 330 
Soy Protein Soy Protein 163 
Dextrinized cornstarch Dextrinized cornstarch 132 
Milk Powder (without 
exosomes) 
    containing ~5% lactose 
Milk Powder (with exosomes) 
   containing ~5% lactose 
105 
Sucrose Sucrose 100 
Soybean oil (no additives) Soybean oil (no additives) 70 
Fiber Fiber 50 
Mineral mix (AIN-93G-MX)1 Mineral mix (AIN-93G-MX) 35 
Vitamin mix (AIN-93G-VX) Vitamin mix (AIN-93-VX) 10 
L-Cystine L-Cystine 3 
Choline bitartrate (41.1% 
choline) 
Choline bitartrate (41.1% choline) 2.5 
Tert-butylhydroquinone Tert-butylhydroquinone 0.014 
 
1Abbreviation used: AIN-93G, American Institute of Nutrition growth diet; MX, mineral 
mixture; VX, vitamin mixture. 
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Abstract 
 
Previous research has demonstrated the bioavailability of milk-borne microRNAs 
following milk consumption by healthy adults. An important question left unanswered at 
the conclusion of that study was if this phenomenon is unique to milk or if other foods 
could also be a source of exogenous microRNA. To explore this possibility, we tested the 
hypothesis that chicken egg microRNAs are bioavailable following consumption of hard 
boiled eggs by healthy adult humans. Plasma concentrations of miR-181b peaked 9 hours 
after egg consumption to 150% above baseline levels. The abundance of miR-181a was 
also increased in erythrocytes 9 hours after egg consumption to levels 154% higher than 
baseline values. Expression of BCL2 and BCL2A1, experimentally validated targets of 
miR-181a/b, was 56% and 19% lower, respectively, in human lymphocytes nine hours 
after egg consumption. We conclude that chicken egg microRNAs are bioavailable and 
have the potential to influence endogenous gene expression in humans following 
consumption of physiologically relevant doses of eggs.   
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Introduction 
 
MicroRNAs (MiRNAs) are a class of small non-coding RNAs about 22 nucleotides long 
that play important roles in gene expression through base-pairing with complementary 
sites at the 3’ untranslated region in target mRNA molecules (1). This binding inhibits 
translation or can cause degradation of target mRNA. The target seed sequence which is 
made of nucleotides 2-7 in microRNA is of particular importance for binding to target 
transcripts (2). Most miRNA are transcribed in the nucleus like protein coding genes and 
are processed in both the nucleus and cytoplasm into the active, mature form. 
Traditionally, the miRNA made within one cell are thought to regulate genes in the same 
cell or perhaps other cells and tissues within the same organism if transported via 
extracellular vesicles (3). This paradigm was recently refuted by a recent publication 
from our lab that has provided strong evidence that humans absorb milk miRNAs that in 
turn have an effect on gene expression (4). Based on these novel and impactful findings, 
we wanted to explore the possibility that other foods could provide exogenous miRNA 
through the diet. To explore that aim, this study analyzed chicken (gallus gallus) eggs as 
a potential dietary source of microRNAs. Eggs are commonly consumed in the United 
States and a good source of nutrients including folate, iron, phosphorous, selenium, zinc 
and vitamins B, E, A and K (5). This study analyzed the expression of chicken specific 
microRNAs as well as those shared between humans and chicken (6, 7).  We analyzed 
miRNA-181a and miR-181b due to their high number of sequence reads in the embryonic 
small RNA library as well as their role in human health. (7) The sequence of miRNA-
181b is homologous between chickens and humans and has been shown to reduce NF-κB 
nuclear translocation resulting in an inhibition of inflammatory gene expression, NF-κB 
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activation and atherosclerosis in mice by targeting importin-α3, a protein used for NF-κB 
translocation to the nucleus. (8) By inhibiting NF-κB translocation, expression of 
inflammatory genes is reduced (9-11). In addition to indirect targeting through regulation 
NF-κB signaling, miR-181a/b also directly target the 3’ UTR of BCL2 mRNA. (12, 13). 
 
Materials and Methods 
Human Feeding Study. Eggs were obtained from a local grocery store and hard boiled the 
night before consumption. Seven healthy adults consumed three different egg doses in a 
randomized crossover design with a minimum of a one week wash out period between 
doses. Subjects were instructed not to consume eggs 24 hours before the egg meal as well 
as during the period of blood sample collection. Twenty milliliters of blood was collected 
in EDTA tubes before egg consumption (Hour 0) and at intervals 3, 4.5, 9, 12, and 24 hr 
after egg consumption. Plasma, PBMC and RBC were collected using gradient 
centrifugation as described previously (14) and frozen at -80°C until analysis. Urine was 
collected throughout the 24 hour length of the study. This protocol was approved by the 
University of Nebraska-Lincoln Institutional Review Board and all participants provided 
signed informed consent forms prior to participation. 
 
RNA Isolation and Reverse Transcription. Total RNA was isolated from 300 uL plasma 
using the NucleoSpin miRNA Plasma kit with a final elution volume of 30 uL (Machery-
Nagel Inc., Bethlehem, PA). For PBMC and RBCs, the Zymo Quick RNA mini-prep kit 
was used with a final elution volume of 30uL (Zymo Research, Irvine, CA). For all 
microRNA studies, 4 uL of RNA was utilized in the miScript RT II Kit (Qiagen, 
Valencia, CA). For reverse transcription of RNA in PBMC samples, 100 ng was used 
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with the miScript RT II Kit using the HiFlex Buffer. Plasma samples were spiked with a 
synthetic internal standard (twenty-five attomoles) prior to extraction of RNA using 
miSPIKE Synthetic RNA (IDT Technologies). 
 
Gene Expression. MicroRNAs were quantified using quantitative real-time PCR as 
described previously. (15) PBMCs were assessed to analyze the effects of egg borne 
miRNA on human gene expression. B-cell lymphoma 2 (BCL2) and BCL2 related 
protein A1 (BCL2A1) were analyzed using samples from 0 h and 9 h post egg 
consumption. Expression of mRNA was normalized to GAPDH expression and 
calculated using the ΔΔCt method. (16) 
 
Pharmacokinetics analysis. The linear trapezoidal rule was used to analyze areas under 
the curve for plasma microRNA to determine the apparent bioavailability of microRNA. 
(17) 
 
Statistics. For all data sets, homogeneity of variances was tested by using the Bartlett’s 
Test. GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA) was used for calculation 
of AUC. Pharmacokinetics data were analyzed using repeated measures analysis of 
variance (ANOVA) and posthoc comparisons were tested with Fisher’s PLSD (18). 
PBMC gene expression data was analyzed using the paired t-test, whereas plasma and 
RBC miRNA were analyzed using the Wilcoxon-Signed Rank Test. StatView 5.0.1 was 
used for statistical analyses (SAS Institute; Cary, NC). Differences were considered 
statistically significant if p<0.05. 
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Results 
 
Bioavailability of egg-borne microRNA. A significant amount of microRNA was 
absorbed by humans following egg meals (Table 1, Fig. 1).  Increases in the plasma miR-
181b concentration were dose-dependent as the consumption of four eggs provided the 
greatest response in Cmax and AUC, followed by the three egg and two egg doses (Table 
1). Plasma concentration of miR-181b peaked 9 h following consumption of the 4 egg 
meal with plasma concentrations returning to baseline values by 24 h after egg 
consumption. The three and two egg doses saw progressively earlier tmax values and 
return to baseline plasma miR-181b concentrations. 
 
Effects of egg microRNA on PBMC and RBC microRNA concentration. Feeding of four 
eggs did not result in changes to human PBMC miRNA concentrations (data not shown). 
In RBCs, miR-181a was 154±41 % higher 9 h following consumption of four eggs (Fig. 
2, P = 0.05) while miR-181b concentrations were not significantly higher. 
 
Target gene expression in response to egg microRNA. Analysis of PBMC at hour 9 post 
egg consumption showed BCL2 and BCL2A1 mRNA to be downregulated. The 
expression of BCL2 was 56±18% lower (Fig. 3, P = 0.05) 9 h following the four egg 
meal compared to baseline and the expression of BCL2A1 was19±3 % lower (Fig. 3, P = 
0.02)  
 
Discussion 
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Few foods are as nutrient dense as eggs. Eggs are abundant in fat soluble vitamins, 
caratenoids, known for their role in disease prevention and are one of the few dietary 
contributors of vitamin K and vitamin D . Eggs are also rich in choline, a nutrient 
important in brain development and memory (5). When compared to egg consumers, non-
consumers were more likely to not meet the RDA for Vitamins A, E and B12 (19). 
Additionally, eggs are considered to be a functional food; meaning they provide added 
physiological benefit beyond that of meeting nutritional needs (5). In spite of these 
positive benefits of consuming eggs, they have received a bad reputation among the 
general public due to concerns of a positive correlation between egg consumption and 
cholesterol (5). Contrary to popular belief, frequent egg consumption has been found to 
be inversely correlated with cholesterol levels (19, 20). While this observation has been 
made by different researchers, there is yet to be a widely accepted mechanism by which 
egg consumption may protect against increased cholesterol levels. 
In a recent study we determined humans absorb meaningful quantities of bovine 
microRNAs, which have an effect on gene expression potentially having human health 
implications. (4) In the present study we observed similar effects regarding egg miRNAs 
following consumption of hard boiled eggs by healthy adults. This paper shows the 
importance of eggs as well as other animal food products on potential implications in 
human health. Many egg borne microRNA are homologous with their human 
counterparts resulting in predictable gene regulation. Among the most abundant miRNAs 
in eggs, miR-181a and miR-181b have well defined physiological roles. These miRNA 
have been shown to inhibit inflammation and atherosclerosis and expression of miRNA-
181b plasma levels are reduced in individuals with atherosclerosis (21). Additionally, 
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atherosclerotic burden was found to be inversely correlated with consumption of one or 
more eggs per week (22). Protection from atherosclerosis may be provided, at least in 
part, by the additional miR-181b provided by egg consumption. Furthermore, egg 
consumption was not associated with risk of coronary heart disease or stroke (20). 
Additionally, patients presenting with sepsis have deceased levels of miR-181b compared 
to control patients (8).  
BCL2 and BCL2A1, known targets of NF-κB, are regulators of cell death exhibiting both 
pro-apoptotic and anti-apoptotic functions. (9, 23) BCL2A1 has commonly been shown 
to be overexpressed in many cancer cells including leukemia and lymphoma, exhibiting 
anti-apoptotic properties by sequestering pro-apoptotic BCL2 family member proteins 
(10, 24, 25).  MiR-181b levels have also been shown to be inversely correlated with 
progressive lymphocytic leukemia and overexpression of BCL2 in contrast to patients 
presenting a stable form of the disease where miR-181b levels remained constant (26).  
In summary, this research clearly demonstrates the bioavailability of chicken egg 
miRNAs after consumption of hard boiled eggs by healthy adults. Importantly, the 
exogenous miRNA also affect endogenous gene expression in PBMC and presumably 
other body tissues. Epidemiological evidence regarding egg consumption supports the 
known role of miR-181a/b with regard to protection from many vascular problems 
including atherosclerosis, inflammation, and sepsis. While we are still in the early stages 
of establishing the importance of dietary miRNAs, this research demonstrates that milk is 
not the only food able to supply exogenous miRNA. While our group and others have 
doubts about the bioavailability of plant miRNAs, results from this study support the 
hypothesis that animal-based food products are dietary sources of miRNA.   
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TABLE 1 Pharmacokinetics analysis of plasma time curves of microRNAs after egg 
meals in healthy adults. 
 
 
miR-181b 
  Dose  
Variable 2 eggs 3 eggs 4 eggs 
Baseline (fmol/L)1 27 ± 15 22 ± 15 27 ± 17 
Cmax (fmol/L) 47 ± 27
a 67 ± 59ab 77 ± 60b 
tmax (h) 4.5 ± 1.2
 7.5 ± 2.9 8.4 ± 2.2 
AUC (fmol/L*h)2  62 ± 51a 133 ± 109a 266 ± 279b 
Values are means ± SD, n=7 
1Plasma concentration at time 0 hours. 
2For hours 0 through 24. 
a,bWithin a variable for the same miRNA, means without a common letter differ (P < 
0.05, n =7). 
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FIGURE 1 Plasma time curves of miR-181b following an egg meal in healthy adults.  
Different doses are represented by colored lines: black (2 eggs), red (3 eggs), and blue (4 
eggs). Values are reported as means, n =7. Standard deviations have been omitted for 
clarity (compare Table 1). 
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FIGURE 2 Effects of egg microRNAs on the abundance of miRNA in human 
erythrocytes. Black bars represent baseline (Hour 0) values and blue bars represent 
miRNA abundance following egg consumption (Hour 9). Values are mean ± SD, n = 7. 
Labeled means without a common letter differ, P < 0.05.  
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FIGURE 3 Effects of egg microRNAs on BCL2 and BCL2A1 gene expression in PBMC 
from healthy adults. Data are mean ± SD, n = 7 (Hour 0, black bars; Hour 9, blue bars). 
Labeled means without a common letter differ, P < 0.05. BCL2, (B-cell lymphoma 2; 
BCL2A1, BCL2-related protein A1. 
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Running head: Loss of miRNAs during processing and storage of milk 
ABSTRACT 1 
MicroRNAs (miRs, miRNAs) play central roles in gene regulation. Previously, we 2 
reported that miRNAs from pasteurized, store-bought bovine milk have biological 3 
activity in humans. Here we assessed the effects of milk processing, storage, somatic cell 4 
content, and handling by consumers on the degradation of miRNAs in milk; we also 5 
quantified miRNAs in dairy products. Pasteurization and homogenization caused a 63% 6 
loss of miR-200c, whereas a 67% loss observed for miR-29b was statistically significant 7 
only in skim milk. Effects of cold storage and somatic cell content were quantitatively 8 
minor (<2% loss). Heating in the microwave caused a 40% loss of miR-29b but no loss of 9 
miR-200c. Milk fat content had no effect on miRNA stability during storage and 10 
microwave heating. The concentrations of miRNAs in dairy products were considerably 11 
lower than in store-bought milk. We conclude that processing of milk by dairies and 12 
handling by consumers causes a significant loss of miRNAs. 13 
 14 
Key words: heating, MiRNAs, milk, processing, storage 15 
  16 
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INTRODUCTION 17 
MicroRNAs (miRs, miRNAs) are small non-coding RNAs that play essential roles in the 18 
regulation of genes at the posttranscriptional level in plants and animals.1 Mature 19 
miRNAs are about 22 nucleotides long and bind to complementary sequences in the 3’-20 
untranslated region of mRNAs. Perfect or near perfect base pairing of the miRNAs and 21 
its target mRNAs typically results in mRNAs degradation, whereas less perfect base 22 
pairing typically results in inhibition of mRNAs translation.2-3 Traditionally, miRNAs 23 
have been considered endogenous regulators of genes, i.e., miRNAs synthesized by a 24 
given host regulate the expression of genes in that host. Recently, our laboratory refuted 25 
this paradigm. We provided strong evidence that 1) humans absorb biologically 26 
meaningful amounts of miRNAs from nutritionally relevant doses of cow’s milk, 2) 27 
physiological concentrations of milk miRNAs affect human gene expression in vivo and 28 
in cell cultures, and 3) endogenous synthesis of miRNAs does not compensate for dietary 29 
miRNA deficiency in mice.4 Our discoveries were largely modeled on miR-29b and miR-30 
200c, but likely hold true for all miRNAs encapsulated in milk exosomes.5-6 To the best 31 
of our knowledge, our previous paper is the first to provide unambiguous evidence that 32 
miRNAs can be transferred between distinct species through dietary means. In contrast, 33 
previous claims that miRNAs from plants affect human gene expression7-8 are highly 34 
controversial and were met with skepticism by the scientific community.4, 9-12 Based on 35 
the above observations, milk miRNAs are a novel class of bioactive food compounds as 36 
defined by the National Cancer Institute in the United States.13 The discovery that milk 37 
miRNAs are bioactive food compounds has broader implications as miRNAs play 38 
essential roles in gene regulation,2-3 cell communication,14-15 and human health.16-23 39 
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This study focused on determining the effect of milk processing, storage, somatic 40 
cell content, and handling by consumers on two miRNAs, miR-29b and miR-200c levels 41 
based on the following rationale. Our rationale for including the somatic cell count in our 42 
analysis was to assess whether an increase in milk cells, as seen in mastitis, might be a 43 
confounder in the analysis of milk miRNAs. In bovine milk, miR-29b and miR-200c are 44 
among the most abundant miRNAs.20 MiR-29b is an important regulator of bone 45 
mineralization in humans, as it increases osteoblast differentiation16 and decreases 46 
osteoclast differentiation and function.17 MiR-200c decreases cancer risk by targeting the 47 
transcription factor ZEB1, which induces E-cadherin expression, thereby limiting 48 
epithelial-to-mesenchymal transition, a key event in metastasis.24-25 Also, the nucleotide 49 
sequences of miR-29b and miR-200c in bovine milk are identical to those of their human 50 
orthologs.26 51 
In Western societies, the majority of milk is processed prior to consumption. In fact, 52 
the production and sale of raw milk dairy products is illegal in many states in the United 53 
States and pasteurization is required.27 Moreover, while the per capita consumption of 54 
milk has declined from 236 pounds in 1982 to 195 pounds in 2012, total dairy 55 
consumption increased by 11% during the same time period.28 Therefore, we considered 56 
it worthwhile to assess the effects of processing on the miRNA content in both milk and 57 
dairy products. 58 
Little is known about the effects of processing and storage on milk miRNAs levels. 59 
In two studies, synthetic miRNAs were added to bovine milk and their stability after 60 
exposure to harsh treatments such as acid and RNase was assessed and compared to the 61 
stability of endogenous miRNAs in milk.6, 20 Synthetic miRNAs were rapidly degraded, 62 
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whereas endogenous miRNAs were resistant to treatment. However, the harsh treatments 63 
applied in these studies are not representative of the treatments applied in commercial 64 
dairy production. In this study, we assessed the effects of pasteurization, fat content, cold 65 
storage, heating as well as processing into dairy products on content of milk miRNAs. 66 
 67 
MATERIALS AND METHODS 68 
Chemicals. Guanidinium thiocyanate and ethanol were purchased for use in the 69 
NucleoSpin miRNA plasma RNA extraction kit (Macherey-Nagel Inc., Bethlehem, PA). 70 
TRIzol was purchased from Life Technologies (Grand Island, NY). 71 
Milk and dairy products. Raw, whole, 2%, and skim cow’s (Bos taurus) milk was 72 
obtained from The Pennsylvania State University Creamery (University Park, PA) from 73 
separate collections in three consecutive weeks in May 2014.  All milk was procured 74 
from the Penn State Animal Science Department’s Holsteins breed herd. Milk was 75 
pasteurized, homogenized, and bottled in the creamery facility within one day of receipt 76 
into bulk tanks.  On our initial collection dates, milk of all fat levels were stored at 4ºC 77 
for up to 15 days, and aliquots were taken and frozen at -80ºC every other day. In a 78 
separate experiment bovine cells were removed from raw milk by centrifugation (500 g, 79 
10 min, 4°C) to determine whether somatic cells are a meaningful confounder when 80 
analyzing the concentrations of miRNAs in milk from healthy cows. Samples were 81 
frozen at -80°C and shipped on dry ice to Lincoln, NE, for miRNA analysis.  Samples 82 
from all fat levels of milk on day 15 were heated in the microwave for 15 seconds and 83 
analyzed after cooling off to room temperature. Dairy products other than milk were 84 
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purchased from grocery stores in Lincoln, NE. All samples were produced and analyzed 85 
as biological repeats in triplicate. 86 
MiRNA analysis. Milk samples were spiked with a synthetic internal standard (twenty-87 
five attomoles) prior to extraction of miRNAs using miSPIKE Synthetic RNA (IDT 88 
Technologies).4 Dairy products (100 mg) other than milk were extracted using TRIzol 89 
prior to addition of the synthetic internal standard. MiR-29b and miR-200c were 90 
quantified using quantitative real-time PCR as described previously.4 91 
Statistics. Analysis by Bartlett’s Test Homogeneity suggested that variances were 92 
homogeneous.29 The paired t-test was used for pairwise comparisons. One-way analysis 93 
of variance (ANOVA) and Fisher’s protected least significant differences were used 94 
when comparing more than two groups. Repeated measures ANOVA was used for 95 
assessing the effects of storage time on miRNA concentration. StatView 5.0.1 (SAS 96 
Institute; Cary, NC) was used for conducting statistical analyses. Means ± SD are 97 
reported. Differences were considered statistically significant if P≤ 0.05. 98 
 99 
RESULTS 100 
Pasteurization and homogenization of raw milk resulted in a 63±28% decrease of 101 
miR-200c in whole milk; effects were similar for 2% fat milk and skim milk (Fig. 1A). 102 
The effect was less pronounced for miR-29b for which a significant decrease (67±18%) 103 
was observed only in skim milk (Fig. 1B).  Cold storage of milk did not affect the 104 
concentration of mir-29b and miR-200c in whole milk, 2% milk and skim milk up to 15 105 
days; 2% fat milk is shown as a representative example in Fig. 2.  Somatic cells are not 106 
meaningful confounds regarding the analysis of miRNAs in milk from healthy cows. 107 
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When somatic cells were removed from raw milk by centrifugation and analyzed for 108 
miRNA content, the cellular miRNAs were found to contribute less than 2% of the total 109 
miRNAs present in raw milk before centrifugation: 1.1±0.9% for miR-29b and 110 
0.14±0.08% for miR-200c. 111 
Processing in the household has the potential to cause a considerable loss of some 112 
miRNAs in milk. For example, the concentration of miR-29b decreased by 40±28% when 113 
processed milk was heated in the microwave and cooled to room temperature compared 114 
to milk before heating (Fig. 3).  In contrast, when milk was heated in the microwave the 115 
concentration of miR-200c was not statistically different compared with unheated 116 
controls.  The concentrations of miRNAs varied considerably among the dairy products 117 
tested (Table 1), but were generally lower than the concentrations in pasteurized whole 118 
milk (compare Fig. 1). Fresco Queso Dip was a notable exception and contained higher 119 
concentrations of miRNAs than those observed in milk. 120 
 121 
DISCUSSION 122 
In a recent paper we reported the importance of milk miRNAs for gene regulation in 123 
humans.4 That report has major implications for the roles of milk and possibly other dairy 124 
products in human health. Cow’s milk contains meaningful quantities of 245 miRNAs,20, 125 
30 and 71.4% of these miRNAs are predicted to target about 11,000 human transcripts 126 
(unpublished observations). In addition to the roles of miR-29b and miR-200c in bone 127 
health and cancer prevention,16-17, 24-25 respectively, miRNAs have been implicated in 128 
various aspects of human health and disease including hypertension, insulin resistance 129 
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and diabetes, hyperlipidemia and atherosclerosis, reproduction, immune function and 130 
Crohn’s disease.18, 20-21, 31-33 131 
We propose that milk has a meaningful effect on human health, mediated by 132 
miRNA-dependent gene regulation. The potential importance of dietary milk miRNA 133 
intake is supported by data suggesting that 1) Americans consume large quantities of 134 
milk and dairy products,28 2) a large proportion of milk miRNAs is encapsulated in 135 
extracellular vesicles, thereby providing protection against degradation 5-6 and a pathway 136 
for cellular uptake by endocytosis,34-35, and 3) milk miRNAs are  resistant against 137 
degradation during storage (this study). 138 
Our previous studies of milk miRNAs in humans and mice were conducted using 1% 139 
fat milk from the grocery store.4 Based on this study, the content of miRNAs is about two 140 
times higher in unprocessed milk compared with pasteurized, store-bought milk. Note 141 
that we have no intent recommending the consumption of raw cow’s milk by humans, 142 
because of food safety concerns associated with raw milk. We observed that a loss of 143 
milk miRNAs occurred only during pasteurization, homogenization, and processing to 144 
dairy products. This observation is consistent with previous studies of milk miRNAs. For 145 
example, endogenous miRNAs were not degraded when milk was exposed to harsh 146 
treatments such as low pH or treatment with RNase.[Kosaka, 2010 #8963; Izumi, 2012 147 
#8911] It is reasonable to propose that encapsulation of miRNAs in extracellular vesicles 148 
[Zhou, 2012, #8913] prevents miRNA degradation, based on the following lines of 149 
evidence. 1) When synthetic miRNAs are added to milk and subjected to low pH or 150 
RNase treatment, the miRNAs are rapidly degraded. [Kosaka, 2010 #8963; Izumi, 2012 151 
#8911] 2) When exosome membranes in milk were disrupted by sonication for preparing 152 
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miRNA-depleted mouse diets in previous studies, miR-29b was rapidly degraded to 153 
concentrations below detection limit.[Baier, 2014 #10339] Presumably, degradation was 154 
due to milk RNases gaining access to miRNAs released from exosomes. 3) When milk 155 
was fermented to produce yoghurt, miRNA concentrations decreased to levels much 156 
lower than in milk (this study). We speculate that the decrease was due to the lysis of 157 
exosomes during fermentation and the large amounts of RNases produced by microbes. 158 
4) When milk was homogenized, miRNA concentrations decreased by on average 50% 159 
(this study). We speculate that the decrease was caused by a disruption of exosome 160 
membranes by shear forces applied during homogenization. Collectively, our studies 161 
suggest that milk, and perhaps dairy products, have the potential to contribute to the 162 
miRNA body pool in humans. 163 
Some uncertainties remain to be addressed in future studies. For example, this study 164 
was modeled based on miR-29b and miR-200c, however, there is a possibility that 165 
distinct miRNAs may be differentially metabolized.8, 36 Another layer of uncertainty is 166 
the possible effects of feeding regimens, season, and breed on the miRNA content in 167 
milk. Moreover, while this study suggests that somatic cells in milk from healthy cows do 168 
not contribute meaningful amounts to the total miRNA content in milk, it is possible that 169 
the increased somatic cell count in milk from cows suffering from mastitis37 may cause 170 
an artificial increase in milk miRNA concentrations. Our previous studies suggest that 171 
plasma miRNA concentrations decrease by 61% in mice fed a milk miRNA-depleted diet 172 
for four weeks. This observation is consistent with milk miRNAs contributing 173 
meaningful quantities to the miRNA body pool, but does not necessarily establish the 174 
essentiality of dietary miRNA intake. Clearly, this is an uncertainty that will need to be 175 
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addressed in future studies. Finally, it is conceivable that miRNAs from foods other than 176 
milk also contribute toward the total body pool of miRNAs. 177 
 178 
ABBREVIATIONS USED 179 
miR, microRNA; miRNA, microRNA 180 
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Figure 1. Loss of miR-200c (A) and miR-29b (B) during milk pasteurization and 
homogenization of milk with different fat content. a,bSignificantly different (n=3 
biological replicates, P<0.05). 
 
  
0 
10 
20 
30 
40 
50 
60 
Raw Whole  2% Skim 
m
iR
-2
9
b
 (
fm
o
l/
L
) 
B) a 
ab 
ab 
b 
0 
500 
1000 
1500 
2000 
2500 
Raw Whole 2% Skim 
m
iR
-2
0
0
c
 (
fm
o
l/
L
) 
A) 
b 
a 
b 
b 
Pasteurization & 
Homogenization 
Pasteurization & 
Homogenization 
 
 
81 
  
 
 
 
 
 
 
 
 
 
 
Figure 2. Storage at 4°C did not affect the concentrations of miR-29b in pasteurized and 
homogenized 2% fat milk (n=3 biological replicates, P>0.05). 
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Figure 3. Loss of miR-29b (A) and miR-200c (B) during heating of whole milk in the 
microwave after 15 days of storage at 4°C. Abbreviation: MW, microwaved. 
a,bSignificantly different (n=3 biological replicates, P<0.05). 
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Table 1. Concentration of miRNAs-29b and -200c in dairy products 
 MiRNA 
  _______________   ______________  
Product miR-29b miR-
200c 
 fmol/kg 
Best Choice Yogurt 0.9±0.10 37.6±2.8 
Fresco Queso Dip  36.1±5.5  1029.8±478.6 
Greek Yogurt  14.2±3.9  462.3±126.9 
Half and Half 3.0±0.17 513.3±159.2 
Heavy Whip Cream 2.6±1.3 342.0±132.9 
Parmesan Cheese                    4.9±1.9                         232.0±64.5 
Upstate Farm Yogurt  2.4±1.0 216.9±93.8 
Data are means±SD, n=3. 
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Abstract 
Sulforaphane is a naturally occurring isothiocyanate in cruciferous vegetables. 
Sulforaphane inhibits histone deacetylases, leading to the transcriptional activation of 
genes including tumor suppressor genes. The compound has attracted considerable 
attention in the chemoprevention of prostate cancer. Here we tested the hypothesis that 
sulforaphane is not specific for tumor suppressor genes but also activates loci such as 
long terminal repeats (LTRs), which might impair genome stability. Studies were 
conducted using chemically pure sulforaphane in primary human IMR-90 fibroblasts and 
in broccoli sprout feeding studies in healthy adults. Sulforaphane and sprouts caused an 
increase in LTR transcriptional activity in cell cultures and adults, respectively. For 
example, the area under the curve for LTR mRNA increased by more than 10 times in 
adults consuming broccoli sprouts compared with controls. The effect of sulforaphane 
was dose dependent in the human feeding studies. This increase in transcript levels was 
associated with an increase in histone H3 K9 acetylation marks in LTR 15 in peripheral 
blood mononuclear cells from subjects consuming sprouts. Collectively, this study 
suggests that sulforaphane has off-target effects that warrant further investigation when 
recommending high levels of sulforaphane intake, despite its promising activities in 
chemoprevention. 
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1. Introduction 
Cruciferous vegetables such as broccoli and cauliflower contain a large number of 
glucosinolates including glucoerucin, glucoiberin, and glucoraphanin (1). When unheated 
vegetables are processed by chopping or chewing, the enzyme myrosinase is released 
from myrosin grains in myrosin cells and glucosinolates are released from adjacent S 
cells (2-4). Myrosinase catalyzes the hydrolytic removal of the glucose moiety in 
glucoraphanin, followed by non-enzymatic release of a hydrogen sulfate moiety and 
spontaneous rearrangement of the unstable intermediate to form the aliphatic 
isothiocyanate sulforaphane (SFN) (1). SFN has attracted considerable attention due to its 
putative role in cancer prevention (5).  
Various, not mutually exclusive, mechanisms have been proposed to explain the 
chemopreventive activities of SFN. One theory is that SFN enhances drug-mediated 
cytotoxicity against cancer cells including cancer stem cells (6-8). The significance of 
these observations is not limited to the chemotherapy of cancer but extends to the 
prevention of cancer through enhancing cellular sensitivity to cell death signals in tumor 
initiation. SFN-dependent inhibition of anti-apoptotic NF-κB signaling pathways appear 
to play a major role in the elimination of abnormal cells (9, 10). A second theory is that 
SFN-dependent inhibition of histone deacetylases (HDACs) causes an increase in the 
expression of tumor suppressor genes such as p21 and Bax, leading to cell cycle arrest 
and apoptosis (11, 12). Evidence suggests that SFN inhibits class I and class II HDACs 
(13). The locus (gene) specificity of SFN is uncertain, despite a general consensus that 
chemoprevention needs to pursue gene-specific gene expression through the modulation 
of epigenetic marks in distinct genomic loci (14). Gene-specific epigenetic editing can, 
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theoretically, be achieved by fusing enzymes or inhibitors to gene-specific DNA binding 
domains. 
In this paper we tested the hypothesis that the inhibition of HDACs by SFN does 
not only de-repress tumor suppressor genes, but also has undesirable off-target effects, 
meditated be de-repression of genes other than tumor suppressor genes. Studies were 
conducted in both cell cultures and healthy adults to take advantage of the small inter-
individual variation in cell cultures and to capture effects of biotransformation in human 
studies. As model loci for detecting off-target effects we used long-terminal repeats 
(LTRs), based on the following rationale.  
LTRs make up about 8% of the human genome and at least 51 LTRs are 
transcriptionally competent (15). Repetitive elements such as LTRs pose a burden to 
genome stability, as their mobilization facilitates recombination between non-
homologous loci, leading to chromosomal deletions and translocations (16, 17). 
Mobilization of LTR transposons is associated with 10% of all spontaneous mutations in 
mice (18). The transcriptional activity of LTRs is controlled by histone acetylation and 
other epigenetic marks; inhibition of HDACs leads to an increase in LTR transcription 
(19). De-repression of LTRs may impair genome stability through insertional 
mutagenesis, recombination events that cause translocations and other rearrangements, 
de-regulation of genes in the host genome mediated by LTR promoter activity, and 
antisense effects if transcription extends into exon sequence downstream of the 
transposon (20). 
 
2. Methods and Materials 
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2.1. Cell cultures  
 
Primary human IMR-90 fibroblasts were obtained from American Type Culture 
Collection (Manassas, VA). We chose primary cells over cell lines to avoid possible 
artifacts caused by the process of immortalization in cell lines. Fibroblasts (from passages 
32-36) were cultured in Minimum Essential Medium (MEM) supplemented with 10% 
fetal bovine serum, 0.1% sodium pyruvate, 100,000 U/L penicillin,100 mg/L 
streptomycin, and 0.1% non-essential amino acids (final concentrations). R,S-SFN was 
obtained from LKT Laboratories (St. Paul, MN) and was dissolved in DMSO to prepare a 
stock solution containing 40 mmol/l SFN. Aliquots were frozen at -20°C until use. SFN 
concentrations in cell culture media were adjusted to a final concentration of 2.0 µmol/l; 
controls were treated with solvent. Samples were collected at timed intervals. 
 
2.2. Human feeding study 
 
Eight apparently healthy adults (4 male, 4 female) participated in a broccoli 
sprout feeding study. Exclusion criteria included pregnancy, smoking, self-reported 
health problems, and use of SFN supplements. Participants in this study included 6 
Caucasians (2 Hispanics) and 2 Asians ages 19-30 years. Subjects were instructed not to 
consume cruciferous vegetables in the 48 hours leading up to the study and during the 
eight-hour period in which blood samples were collected. Each subject consumed three 
doses (34 g, 68 g, 102 g) of BroccoSprouts® broccoli sprouts from a local supermarket 
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(HyVee, Lincoln, NE). Sprouts were consumed with a bagel and cream cheese (11). Each 
treatment was separated by a two week washout period and the order of doses was 
randomized. Thirty milliliters of blood were collected before sprout consumption 
(baseline, time 0 h) and at timed intervals (2, 4, and 8 h) after consumption. Peripheral 
blood mononuclear cells (PBMC) and plasma were purified using Histopaque and 
gradient centrifugation as described previously (21); aliquots were frozen at -80°C until 
analysis. 
  
2.3. Quantitation of SFN 
SFN was extracted and quantitated by HPLC as previously described (22). 
Briefly, 1 g of BroccoSprouts® was combined with 20 ml of water acidified with 0.1 M 
hydrochloric acid and homogenized for 10-15 seconds with a Tissue-Tearor model 
985370 hand-held homogenizer (Biospec Products, Inc., Bartlesville, OK). Extracts were 
transferred to a 45°C water bath for 2 hours and then cooled to room temperature. The 
solution was extracted twice with 20 ml dichloromethane and the solvent phases were 
collected and combined. The solvent was dried through sodium sulfate and then loaded 
onto a Supelclean™ LC-Florisil® SPE column (Supelco). The column was washed with 
3 ml ethyl acetate and SFN was collected with 3 ml methanol. Samples were passed 
through a 0.2 μm filter and stored at -20°C until analysis. Determination of SFN 
concentration was performed by injection on a Waters (Milford, MA) 600S HPLC system 
equipped with a VyDac C18 (Grace, Deerfield, IL) column and a Waters 2996 
Photodiode Array detector. Separation was achieved with an isocratic flow rate of 1.0 
ml/min using water and acetonitrile (30:70 v/v). A sample volume of 20 μl was injected. 
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2.4. Quantitative Real-Time PCR (qRT-PCR) 
 
The abundance of p21 mRNA and LTR mRNA (transcript R/U5) was quantified 
by qRT-PCR as previously described using the cycle threshold method; glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used to normalize for PCR efficiency (23, 
24). PCR primer sequences for p21 were 5’-AGGCGGTTATGAAATTCACC-3’ 
(forward) and 5’-CCCTTCAAAGTGCCATCTG-3’ (reverse). LTR primer sequences 
were the same as previously reported (25). Note that the values for LTR mRNA represent 
the grand total of all transcriptionally active LTRs due to near-identical sequences in 
these repeats (25). Areas under the curves (AUCs) for LTR mRNA were calculated using 
the linear trapezoidal rule (26). 
 
2.5. Chromatin Immunoprecipitation (ChIP) assays 
 
ChIP assays were performed as previously described (23). Antibody against K9-
acetylated histone H3 (H3K9ac; ab10812) was purchased from Abcam (Cambridge, 
MA). Data were normalized for nucleosomal occupancy using an antibody to the C-
terminus in histone H3. The enrichment of H3K9ac marks in LTR15 {nomenclature as 
per (15)} were quantified by qRT-PCR, using GAPDH as a control. PCR primer 
sequences were the same as in our previous studies (25). In case of ChIP assays, as 
opposed to mRNA quantification, individual LTRs can be distinguished by having one 
PCR primer anneal with sequences in the host genome adjacent to the LTR of interest. 
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2.6. Statistics  
 
Homogeneity of variances was tested using Bartlett’s Test. If variances were 
heterogeneous, data was log transformed before analysis. Data from IMR90 cell cultures 
were analyzed by using the Wilcoxon Signed-Rank Test. Data from PBMC experiments 
were analyzed using one-way analysis of variance (ANOVA) and Fisher’s LSD for 
posthoc comparisons (27) for gene expression data and Wilcoxon Signed-Rank Test for 
ChIP data. Differences were considered statistically significant if p<0.05. StatView 5.0.1 
was used for conducting statistical analyses (SAS Institute; Cary, NC). 
 
3. Results 
 
3.1. LTR transcript levels increase after SFN treatment in IMR-90 fibroblast cultures 
 
SFN de-repressed LTRs in IMR-90 fibroblasts (Fig. 1). A significant increase in 
LTR mRNA was detectable at t = 4 h, and peak values were achieved at t = 6 h compared 
with vehicle controls. LTR expression levels returned to baseline levels after 16 h of SFN 
treatment. The expression of the p21 tumor suppressor also increased in response to SFN 
treatment (Fig. 2), consistent with previous reports in BPH-1, LnCaP, and PC-3 prostate 
epithelial cells (28), but this increase in p21 mRNA was not statistically significant. 
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3.2. Human consumption of broccoli sprouts increases LTR expression and histone 
acetylation 
 
The expression of LTRs increased dose-dependently in response to consumption 
of broccoli sprouts, as judged by the AUCs for LTR mRNA in PBMC (Fig. 3). The 
AUCs for LTR transcripts in subjects consuming 34 g, 68 g, and 102 g sprouts were 1.29 
± 2.38, 5.54 ± 5.26, and 13.06 ± 23.68 arbitrary units, respectively, compared with 
baseline. The increase was significantly greater for the 68 g and 102 g doses compared 
with the 34 g dose (p<0.05, N=8). The AUCs for p21 mRNA in subjects consuming 34 g, 
68 g, and 102 g sprouts were 0.80 ± 1.43, 0.73 ± 0.90, 2.46 ± 3.00 arbitrary units, 
respectively, compared with baseline; however the differences were not statistically 
significant (p>0.05, N=8). Note that the level of SFN in Broccosprouts® was 18 mg/g 
fresh weight. 
The de-repression of LTRs was associated with an increased abundance of 
H3K9ac marks in LTR15 at t = 4 h compared with t = 0 h (Fig. 4A). The magnitude of 
the effect depended on the amount of broccoli sprouts that was consumed; meaningful 
increases in H3K9ac enrichment at t = 4 h were observed when sprout doses exceeded 34 
g (Fig. 4B). 
 
4. Discussion 
 
To the best of our knowledge, this is the first report suggesting possible off target 
effects of SFN in the de-repression of LTRs in both primary cells and human feeding 
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studies. The increase in LTR mRNA abundance was not only statistically significant but 
also appears to be of biological importance, considering that the AUC for LTR mRNA 
increased by more than 10 times for the highest dose of broccoli sprouts. The doses tested 
in cell cultures and feeding studies are nutritionally relevant (29). Our observations were 
corroborated by an increase in the abundance of H3K9ac marks in LTRs, consistent with 
their de-repression. Note that SFN also increased the expression of the tumor suppressor 
gene p21, albeit to a smaller extent than previously reported (30). The comparably small 
increase in p21 expression in response to SFN might be due to us using nutritionally 
meaningful levels, whereas other studies typically concentrations of at least 15 µmol/l 
SFN (9, 31-33). 
Our observations are important for human health, considering the roles of LTRs 
in impairing genome stability (see Introduction) and the widespread availability of SFN-
containing foods and supplements. The sprouts used in this study, Broccosprouts®, are 
widely available in the United States; the lowest dose that was tested, 34 g, is about one 
serving according to product labeling. One serving of broccoli sprouts may contain levels 
of SFN sufficient to de-repress LTRs. SFN-containing supplements are also available to 
consumers over the counter. To the best of our knowledge, there are no data available for 
the consumption of SFN supplements in the United States, but supplement use in general 
is fairly common. For example, approximately 50% of all Americans and 64-81%, of 
cancer survivors take nutritional supplements (34). Of the many SFN supplements on the 
market, wide ranges of doses are available. One product, BroccoMax® is a supplement 
labeled as having 30 mg sulforaphane glucosinolate per serving, providing a dose of SFN 
similar to the dose tested in this study. One could assume with a reasonable level of 
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confidence that consuming such doses of SFN on a regular basis could elicit effects 
exceeding those seen in this study where single doses were administered. Note that we do 
not dispute the potential benefits of SFN in the chemoprevention of cancer (6-8, 11, 12). 
However, we propose that SFN needs to be considered in the context of gene-specific 
editing (14). 
There are some uncertainties that need to be addressed in future studies. First, the 
effects of SFN on the de-repression of LTRs (and p21) are transient, and it remains to be 
determined whether a de-repression that last a few hours is sufficient to elicit biologically 
meaningful effects. Second, while the de-repression of LTRs was quantitatively 
important, it remains to be seen whether the observed increase in LTR expression is 
sufficient to impair genome stability. 
Collectively, this study suggests that sulforaphane has off-target effects that 
warrant further investigation when recommending high levels of sulforaphane intake, 
despite its promising activities in chemoprevention. 
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Fig. 1. SFN increases LTR transcription in IMR-90 fibroblast cultures. Fibroblasts were 
treated with 2.0 µmol/l SFN (squares) or solvent (triangles). *Significantly different 
compared with vehicle control at the same collection time (p<0.05 by Wilcoxon Signed-
Rank test, N=4-7).   
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Figure 2 
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Fig. 2. SFN had no significant effect on p21 transcription in IMR-90 fibroblast cultures. 
Fibroblasts were treated with 2.0 µmol/l SFN (squares) or solvent (triangles). 
*Significantly different compared with vehicle control at the same collection time 
(p<0.05 by Wilcoxon Signed-Rank test, N=4-7). 
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Figure 3 
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Fig. 3. AUC for LTR (black bars) and p21 (gray bars) expression increases in a dose-
dependent manner following three broccoli sprout doses in healthy adults. Statistical 
significance determined by ANOVA with Fisher’s LSD used for posthoc comparisons. 
a,bColumns not sharing the same letters are significantly different for the same treatment 
group (SFN vs. control; p<0.05, N=8). 
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Figure 4 
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Fig 4. (A) Broccoli sprout consumption increases enrichment of H3K9ac mark in LTR15 
in PBMCs from human subjects consuming 102 g broccoli sprouts. *Significantly 
different than controls as per Wilcoxon Signed-Rank test (p<0.05, N=8). (B) Dose-
response curve for the H3K9ac mark in LTR15 in PBMCs from a representative subject. 
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Figure 4B 
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OUTLOOK 
The concept of dietary microRNAs is still relatively new in the nutrition field and while 
the potential importance of bioavailable nucleic acids cannot be overlooked, much more 
work needs to be done before we fully understand the function and impact of these 
molecules. Initial reports indicating the bioavailability of plant-based microRNAs have 
largely been refuted, but the results presented here in favor of milk and egg-derived 
microRNA availability show there is great potential for dietary microRNA-based gene 
regulation that may result in phenotypic changes on the organism level. To investigate 
dietary microRNA further, certain projects are underway and planned that will greatly 
increase our knowledge in this area. 
 
1. Sonicated milk/eggs feeding study 
 
Sonication of milk was used in making the ExoMinus diet in the mouse feeding study 
presented in Chapter I. While not initially planned as part of the human feeding study, we 
now have started another study with feeding subjects 1.0 L of sonicated milk. Since most 
miRNA do not remain in the milk following sonication, the expected response in regard 
to plasma miRNA concentrations and resulting PBMC gene expression changes should 
not occur, or at least to a much lesser extent. This study will provide important evidence 
showing the changes in miRNA abundance and gene expression in tissues are truly due to 
exogenously supplied miRNA. Similar studies will also be performed for the egg feeding 
study presented in Chapter II. 
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2. Mouse phenotyping study 
 
In Chapter I, a short term mouse feeding study was presented where mice were fed diets 
named ExoPlus, meaning it was sufficient in exosomal/microRNA content or ExoMinus, 
where the microRNA were depleted by sonication. While this study provided interesting 
results showing mice are not able to make up for decreased dietary microRNA by 
upregulating endogenous genes, it was likely too short of a study and too few mice to 
determine phenotypic effects of long-term consumption of milk microRNAs. Currently, a 
larger study is underway where mice are being fed the same two diets with tissue 
collections occurring at different time points throughout life. In addition, breeding 
success and the viability and success of offspring will be measured. Also, unlike the pilot 
study, both male and female mice will be included to examine any potential gender 
specific effects. 
 
3. Comparison of milk and dairy consumers versus non-consumers 
 
One of the outcomes of the pilot study in mice from Chapter I was the observation that 
some liver metabolites were present in different levels when comparing mice on the 
ExoPlus versus ExoMinus diets. In particular, metabolites in the purine metabolism 
pathway, including xanthine and uric acid, were more abundant in the livers of mice on 
the ExoMinus diet. This observation has also been made in human plasma samples when 
comparing two consumers of milk to one non-consumer. While in the early stages, the 
encouraging results from the mouse study and limited analysis of human samples has let 
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us to begin recruitment of more individuals for the human sample analysis. In addition to 
plasma samples, 24 hour urine collections will be performed to allow for analysis of urine 
metabolites. 
 
4. Fortification of infant formulas with milk-derived exosomes 
 
One of the observations made in our lab is breast milk has significantly greater amounts 
of miRNA than infant formulas. This is probably due, in part, to the large effect 
processing has on the abundance of miRNA in milk (see Chapter III). Additionally, plant 
based formulas contain none of the same miRNA as naturally found in breast milk. If 
possible, the addition of milk exosomes into formula powder preparations could improve 
the overall nutritional profile of infant formulas and make up for the differences in the 
health outcomes of infants on formula-based diets compared to breast-fed counterparts. 
This study will be performed by feeding human adults two different 1.0 L drinks. One 
will be a soy infant formula mixed according to label recommendations. The other will be 
the same formula with supplemented cow’s milk exosomes to obtain a similar miRNA 
profile as seen in cow’s milk. Theoretically there will not be a change to plasma miRNA 
following consumption of soy formula alone, but the supplemented formula should result 
in plasma miRNA increases similar to that of the study perform in Chapter II.  
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5. Determination of bone health in infants based on feeding regimen 
 
Infants fed breast milk have greater BMD for the first few months of life compared to 
formula fed infants. We hypothesize the miRNA in breast milk may be partially 
responsible for this difference (see the effects of miR-29b in Chapter I) and are in the 
process of collecting samples from infants on different diets. In this study, mothers are 
providing milk samples, both breast milk and formula milk, and collecting infant urine 
once monthly until 6 months of age. The urine and milk miRNA content will be analyzed 
as well as the presence of different markers of bone health in the urine. We expect that 
the miRNA content of the infant’s diet impacts markers of bone formation and 
breakdown. This study has enrolled a few infant/mother pairs and active recruitment is 
currently underway. 
 
6. Use of milk-derived exosomes as drug delivery vehicles 
 
Cow’s milk exosomes are widely available and cheap to obtain when compared to 
exosomes produced in cell culture chambers. Additionally, since many cell cultures are 
from cancer cell lines, there are many concerns about the exosomes derived from those 
cells having the potential to transfer the cancer phenotype to recipient cells. Since we 
have observed encouraging results from the studies present in this dissertation and from 
the work of other students, pilot studies were performed regarding drug loading of 
exosomes. By using electroporation we have been able to transfect exosomes with drug 
and plasmid DNA and subsequently measure uptake by recipient cells treated with the 
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transfected exosomes. This project is in the early stages, but once conditions are 
optimized it may open the door for use of bovine milk exosomes as an inexpensive way 
to package drugs that cannot currently be consumed orally because of degradation in the 
gastrointestinal tract. 
 
 
